Oncology Ablation Market Report 2026

Oncology Ablation Market Overview

• Oncology Ablation market size has reached to $1.45 billion in 2025 • Expected to grow to $2.61 billion in 2030 at a compound annual growth rate (CAGR) of 12.4% • Growth Driver: Impact Of Increasing Cancer Diagnoses On The Oncology Ablation Market • Market Trend: Innovative Developments In Oncology Ablation Technology Boost Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oncology Ablation Market?

Oncology ablation refers to a minimally invasive procedure used to destroy cancerous tumors. It involves the application of extreme conditions directly to the tumor tissue. This technique aims to reduce or eliminate tumors while sparing surrounding healthy tissue. The main technologies of oncology ablation are radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation ablation. Radiofrequency ablation refers to a medical procedure that uses radiofrequency energy to generate heat and destroy abnormal tissue or nerve pathways. Various treatments include surgical ablation, laparoscopic ablation, and percutaneous ablation. This technology is applied in treating cancers such as kidney cancer, liver cancer, breast cancer, lung cancer, and prostate cancer.

What Is The Oncology Ablation Market Growth Forecast?

The oncology ablation market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to growth in targeted and personalized ablation therapies, increasing adoption of percutaneous and laparoscopic ablation techniques, technological advancements in ablation equipment, expansion of oncology centers in emerging regions, rising integration of digital patient management and monitoring systems. Major trends in the forecast period include rising adoption of digital platforms for oncology ablation procedure management, increasing integration of ai and machine learning in tumor diagnosis and planning, growing implementation of precision medicine and genomic profiling for ablation therapy, rising automation in ablation devices and surgical equipment, increasing iot-enabled monitoring of ablation devices and patient outcomes.

What Is The Driver Of The Oncology Ablation Market?

The increasing number of cancer diagnoses is expected to propel the growth of the oncology ablation market going forward. Cancer diagnosis refers to the process of identifying and confirming the presence of cancer through medical tests, imaging, and pathological analysis of tissue samples. The rising number of cancer diagnoses is due to several factors, such as aging populations, improved screening programs, heightened awareness leading to earlier detection, and environmental factors. Oncology ablation is used to treat tumors detected through cancer diagnoses, offering minimally invasive options to destroy tumors and improve patient outcomes. For instance, in May 2024, according to the National Cancer Institute, the US-based federal government's principal agency for cancer research and training, around 2,001,140 new cancer cases are expected in the United States in 2024, with prostate, lung, and colorectal cancers comprising approximately 48% of all diagnoses in men. By 2040, the annual number of new cancer cases is projected to surge to 29.9 million, highlighting a significant future increase in cancer incidence. Furthermore, in June 2022, according to the American Cancer Society, a US-based non-profit cancer awareness organization, around 1.9 million new cancer cases were diagnosed in the USA in 2022. Therefore, an increasing number of cancer diagnoses will drive the oncology ablation industry.

Key Players In The Global Oncology Ablation Market

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Global Oncology Ablation Market Trends and Insights

Major companies operating in the oncology ablation market are developing innovative products such as advanced ablation systems with improved precision, integrated imaging technologies for real-time guidance, and enhanced safety features. Advanced ablation systems with improved precision refer to medical devices that use advanced technology to precisely target and destroy abnormal tissue, such as tumors, while minimizing damage to surrounding healthy tissue. For instance, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, received US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, designed to treat painful bone metastases and benign tumors like osteoid osteoma. This upgraded system features significant enhancements, including the ability to use four internally cooled probes simultaneously, allowing for the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

What Are Latest Mergers And Acquisitions In The Oncology Ablation Market?

In February 2024, AngioDynamics, a US-based manufacturer of oncology ablation devices, partnered with Immunophotonics, Inc., to explore the combination of AngioDynamics’ ablation devices with Immunophotonics’ lead immunotherapy asset, IP-001, for the treatment of solid tumor cancers. Through this partnership, both companies aim to advance interventional immuno-oncology by leveraging the synergistic potential of ablation and immunotherapy in clinical settings. Immunophotonics, Inc. is a US-based biotechnology company focused on developing innovative immunotherapy solutions for solid tumor cancers.

What Defines the Oncology Ablation Market?

The oncology ablation market consists of revenues earned by entities by providing services such as tumor removal, reduction, and management of metastatic cancer lesions. The market value includes the value of related goods sold by the service provider or included within the service offering. The oncology ablation market also includes sales of high-intensity focused ultrasound (HIFU) devices, laser ablation devices, and electromagnetic ablation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oncology Ablation Market Report 2026?

The oncology ablation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology ablation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.